Progesterone and vitamin K for the prevention of erythroblastosis fetalis.
D000933:Antifibrinolytic Agents; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005333:Fetus; D006490:Hemostatics; D006801:Humans; D007231:Infant, Newborn; D011374:Progesterone / Q000627:therapeutic use*; D014812:Vitamin K / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D014812:Vitamin K; D011374:Progesterone
ERYTHROBLASTOSIS, FETAL/prevention and control; PROGESTERONE/therapeutic use; VITAMIN K/therapeutic use